We Give Hope

Hope by the Sea has helped, healed and given hope to thousands through our accredited addiction programs and services.
The miracle of recovery can be yours too.

CHOOSE A PROGRAM

Tuesday, January 6, 2015

FDA Approves Injectable Non-Opioid Painkiller

Prescription drug companies in the United States continue to seek out effective ways for treating moderate to severe pain without the use of opioid narcotics, drugs which have brought many Americans to their knees. Opioids are the most effective substances on the planet for the treatment of pain, but such drugs are highly addictive and if used improperly can be fatal - a double edge sword of epic proportions.

While the problem has been recognized, doing something about it has proven extremely difficult, although researchers are working tirelessly to find alternatives. The pharmaceutical company, Hospira Inc, announced that the U.S. Food and Drug Administration (FDA) had granted approval for its non-opioid injection, Dyloject™ (diclofenac sodium), a non-steroidal anti-inflammatory drug that provides fast relief to patients suffering moderate to severe pain, Reuters reports.

What separates Dyloject™ from other injectable non-opioid painkillers is that it can be administered within 15 seconds, whereas other drug of that class require dilution prior to administration, needing an infusion of 15 to 30 minutes for a full dose, according to Hospira. Dyloject™ can be used with other non-opioid painkillers and can be administered alone.

"In today's healthcare environment, pain management and patient satisfaction are important to hospitals. As a result, various medical organizations are now recommending a multi-modal approach to pain control in an effort to minimize the use of opioids," said Sumant Ramachandra, M.D., Ph.D., senior vice president and chief scientific officer, Hospira. "As a leading supplier of hospital pain management medication, Hospira's Dyloject™ will be a complementary addition to our existing portfolio of acute-care drugs, providing clinicians an additional non-opioid option that can be administered quickly and conveniently to treat pain."

The company points out that Dyloject™ is not a replacement for opioids, but rather an aid in reducing the amount of opioids used on a given patient.

No comments:

Post a Comment

Thanks for your comment!

CignaAetnaBlueCross BlueShieldUnited HealthcareMore Options/Verify Benefits

START THE ADMISSION PROCESS

866.930.4673